Skip to Content

Join the 'Bextra' group to help and get support from people like you.

Bextra News

Giving the 'Green Light' to Migraine Relief

Posted 17 May 2016 by Drugs.com

TUESDAY, May 17, 2016 – A new study sheds light – literally – on a potential means of easing migraine pain. Researchers in Boston exposed 69 migraine patients to different colors of light. They found that while blue light exacerbated headache pain, a narrow spectrum of low-intensity green light significantly reduced light sensitivity. In some cases, this green light also reduced migraine pain ...

X-Rays May Miss Hip Arthritis, Study Finds

Posted 10 Dec 2015 by Drugs.com

THURSDAY, Dec. 10, 2015 – X-rays don't detect hip arthritis in many patients, resulting in delayed diagnosis and treatment, researchers report. The researchers looked at information from almost 4,500 Americans taking part in two arthritis studies. In one study, only 16 percent of patients with hip pain had X-ray evidence of osteoarthritis in the hip and only 21 percent of those with X-ray ...

Certain Painkillers Tied to Raised Risk of Death After Stroke

Posted 5 Nov 2014 by Drugs.com

WEDNESDAY, Nov. 5, 2014 – Arthritis pain relievers known as COX-2 inhibitors, including Celebrex and Lodine, are associated with an increased risk of dying within a month after a stroke, according to a new study. "This large study from Denmark adds to the prior concerns about COX-2 inhibitors and stroke risks," said Dr. Ralph Sacco, chairman of neurology at the University of Miami Miller School ...

Common Painkillers May Help Prevent Skin Cancer: Study

Posted 29 May 2012 by Drugs.com

TUESDAY, May 29 – Taking nonsteroidal anti-inflammatory drugs (NSAIDs) – which include medicine cabinet staples such as aspirin, Motrin and Aleve – appears to significantly lower the risk for developing several major forms of skin cancer, a new Danish study reveals. What's more, the apparent protective impact of both prescription and nonprescription NSAIDs on skin cancer risk seems to be ...

Scientists Spot How Cox-2 Painkillers Raise Heart Risks

Posted 2 May 2012 by Drugs.com

WEDNESDAY, May 2 – New research has uncovered how some cox-2 painkillers increase the risk for both heart attacks and stroke. The once popular cox-2 drugs, Vioxx and Bextra, were pulled off the market in 2004 and 2005, respectively, after research showed that both raised the chances of cardiovascular trouble. Meanwhile, Celebrex, a painkiller in the same drug class that remains on the market, ...

Some Pain Meds Riskier for Cardiac Patients Than Others, Study Suggests

Posted 28 Sep 2011 by Drugs.com

From Canadian Press DataFile (September 27, 2011) By Helen Branswell TORONTO – A new study suggests some commonly consumed pain medications are riskier than others when used by people with cardiovascular problems. The research suggests a couple of the drugs carry the same level of risk as Vioxx, which was taken off the market in 2004 over heart health concerns. Senior author Dr. David Henry says ...

Painkillers May Raise Risk of Dangerous Heart Flutter

Posted 5 Jul 2011 by Drugs.com

TUESDAY, July 5 – A new study finds that painkillers widely used to treat inflammation are associated with an increased risk of atrial fibrillation, a heart rhythm disorder connected with a raised risk of stroke, heart failure and death. Previous research has linked non-steroidal anti-inflammatory drugs (NSAIDs) and newer anti-inflammatory medications known as cox-2 inhibitors to an increased ...

FDA Medwatch Alert: Bextra (valdecoxib - Apr 7, 2005

Posted 7 Apr 2005 by Drugs.com

After concluding that the overall risk versus benefit profile is unfavorable, FDA has requested Pfizer, Inc. to voluntarily withdraw Bextra (valdecoxib) from the market. This request is based on: * The lack of adequate data on the cardiovascular safety of long-term use of Bextra, along with the increased risk of adverse cardiovascular (CV) events in short-term coronary artery bypass surgery ...

FDA Medwatch Alert: Bextra (valdecoxib) - Jun 15, 2005

Posted 15 Jun 2005 by Drugs.com

FDA has requested that sponsors of all non-steroidal anti-inflammatory drugs (NSAID) make labeling changes to their products. FDA recommended proposed labeling for both the prescription and over-the-counter (OTC) NSAIDs and a medication guide for the entire class of prescription products. All sponsors of marketed prescription NSAIDs, including Celebrex (celecoxib), a COX-2 selective NSAID, have ...

FDA Medwatch Alert: Bextra (valdecoxib) - Dec 10, 2004

Posted 10 Dec 2004 by Drugs.com

The FDA announced important new information on side effects associated with the use of Bextra, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID) indicated for the treatment of osteoarthritis, rheumatoid arthritis and dysmenorrhea (menstrual pain). A "boxed" warning, strengthening previous warnings about the risk of life-threatening skin reactions, and a new bolded warning ...

FDA Medwatch Alert: Bextra (valdecoxib) - Nov 15, 2002

Posted 15 Nov 2002 by Drugs.com

FDA and Pharmacia/Pfizer strengthened the CONTRAINDICATIONS, WARNINGS, and ADVERSE REACTIONS sections of the prescribing information. In postmarketing experience, rare reports of hypersensitivity reactions (i.e, anaphylatic reactions and angioedema) and skin reactions, including cases of Stevens-Johnson syndrome, toxic epidermal necrolysis, exfoliative dermatitis, and erythema multiforme, have ...

FDA Medwatch Alert: COX-2 Selective and Non-Selective Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

Posted 15 Jun 2005 by Drugs.com

After concluding that the overall risk versus benefit profile is unfavorable, FDA has requested Pfizer, Inc. to voluntarily withdraw Bextra (valdecoxib) from the market. This request is based on: * The lack of adequate data on the cardiovascular safety of long-term use of Bextra, along with the increased risk of adverse cardiovascular (CV) events in short-term coronary artery bypass surgery ...

Ask a Question

Further Information

Related Condition Support Groups

Pain, Osteoarthritis, Period Pain, Dysmenorrhea, Rheumatoid Arthritis

Bextra Patient Information at Drugs.com